Viewing Study NCT01439750


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2025-12-27 @ 1:21 PM
Study NCT ID: NCT01439750
Status: UNKNOWN
Last Update Posted: 2017-08-07
First Post: 2011-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
Sponsor: Milton S. Hershey Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module